364 related articles for article (PubMed ID: 31379872)
1. Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Flynn JK; Dankers W; Morand EF
Front Immunol; 2019; 10():1684. PubMed ID: 31379872
[TBL] [Abstract][Full Text] [Related]
2. Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ).
Dankers W; Northcott M; Bennett T; D'Cruz A; Sherlock R; Gearing LJ; Hertzog P; Russ B; Miceli I; Scheer S; Fujishiro M; Hayakawa K; Ikeda K; Morand EF; Jones SA
Front Immunol; 2022; 13():1034880. PubMed ID: 36505447
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease.
Cappetta D; Bereshchenko O; Cianflone E; Rossi F; Riccardi C; Torella D; Berrino L; Urbanek K; De Angelis A; Bruscoli S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440924
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis.
Sevilla LM; Pérez P
Front Immunol; 2019; 10():2220. PubMed ID: 31572404
[TBL] [Abstract][Full Text] [Related]
6. [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids].
Riccardi C
Ann Ig; 2010; 22(1 Suppl 1):53-9. PubMed ID: 20701225
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action.
Ayroldi E; Riccardi C
FASEB J; 2009 Nov; 23(11):3649-58. PubMed ID: 19567371
[TBL] [Abstract][Full Text] [Related]
8. GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects Against End-Organ Damage in a Model of Lupus.
Nataraja C; Dankers W; Flynn J; Lee JPW; Zhu W; Vincent FB; Gearing LJ; Ooi J; Pervin M; Cristofaro MA; Sherlock R; Hasnat MA; Harris J; Morand EF; Jones SA
Front Immunol; 2021; 12():652800. PubMed ID: 33889157
[TBL] [Abstract][Full Text] [Related]
9. Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation.
Cannarile L; Delfino DV; Adorisio S; Riccardi C; Ayroldi E
Front Immunol; 2019; 10():1823. PubMed ID: 31440237
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.
Mohammadi S; Ebadpour MR; Sedighi S; Saeedi M; Memarian A
Clin Rheumatol; 2017 Aug; 36(8):1765-1772. PubMed ID: 28601944
[TBL] [Abstract][Full Text] [Related]
11. GILZ regulates type I interferon release and sequesters STAT1.
Nataraja C; Flynn J; Dankers W; Northcott M; Zhu W; Sherlock R; Bennett TJ; Russ BE; Miceli I; Pervin M; D'Cruz A; Harris J; Morand EF; Jones SA
J Autoimmun; 2022 Jul; 131():102858. PubMed ID: 35810690
[TBL] [Abstract][Full Text] [Related]
12. Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.
Cheng Q; Morand E; Yang YH
Front Pharmacol; 2014; 5():169. PubMed ID: 25100999
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.
Berrebi D; Bruscoli S; Cohen N; Foussat A; Migliorati G; Bouchet-Delbos L; Maillot MC; Portier A; Couderc J; Galanaud P; Peuchmaur M; Riccardi C; Emilie D
Blood; 2003 Jan; 101(2):729-38. PubMed ID: 12393603
[TBL] [Abstract][Full Text] [Related]
14. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression.
Yang N; Zhang W; Shi XM
J Cell Biochem; 2008 Apr; 103(6):1760-71. PubMed ID: 17910039
[TBL] [Abstract][Full Text] [Related]
16. Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19.
Mozaffari MS
J Pharmacol Exp Ther; 2020 Dec; 375(3):398-405. PubMed ID: 33008869
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule.
Bereshchenko O; Migliorati G; Bruscoli S; Riccardi C
Front Pharmacol; 2019; 10():308. PubMed ID: 30971930
[TBL] [Abstract][Full Text] [Related]
18. [Primary investigation of the relationship between glucocorticoid induced leucine zipper and inflammatory reaction].
Bai XJ; Li B; Wang HP; Yang ZH; Li SQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):7-10. PubMed ID: 17207354
[TBL] [Abstract][Full Text] [Related]
19. GILZ as a Mediator of the Anti-Inflammatory Effects of Glucocorticoids.
Ronchetti S; Migliorati G; Riccardi C
Front Endocrinol (Lausanne); 2015; 6():170. PubMed ID: 26617572
[TBL] [Abstract][Full Text] [Related]
20. GILZ as a Regulator of Cell Fate and Inflammation.
Bruscoli S; Riccardi C; Ronchetti S
Cells; 2021 Dec; 11(1):. PubMed ID: 35011684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
